Tag: Capsule excipients

High Variability in Shell Thickness Affecting Dissolution Rates Addressing High Variability in Shell Thickness Affecting Dissolution Rates Context Capsule shell thickness plays a critical role in controlling the drug release profile and ensuring consistent dissolution behavior. Variability in capsule shell thickness can significantly affect the dissolution rate, leading to inconsistent drug release, and consequently, affecting…

Read More “High Variability in Shell Thickness Affecting Dissolution Rates” »

Limited Scalability of Innovative Capsule Dosage Forms Addressing the Limited Scalability of Innovative Capsule Dosage Forms Context While innovative capsule dosage forms, such as those incorporating advanced drug delivery systems, offer numerous advantages in terms of drug efficacy and patient compliance, scaling up these formulations from laboratory-scale development to commercial manufacturing can be challenging. Factors…

Read More “Limited Scalability of Innovative Capsule Dosage Forms” »

Challenges in Achieving a Balance Between Solubility and Stability Addressing the Challenges in Achieving a Balance Between Solubility and Stability in Capsule Formulations Context In pharmaceutical formulations, especially for poorly soluble drugs, achieving an optimal balance between solubility and stability is critical to ensure both therapeutic efficacy and long-term product performance. While enhancing the solubility…

Read More “Challenges in Achieving a Balance Between Solubility and Stability” »

High Development Costs for Incorporating Advanced Drug Delivery Technologies in Capsules Addressing High Development Costs for Incorporating Advanced Drug Delivery Technologies in Capsules Context Incorporating advanced drug delivery technologies into capsule formulations can significantly enhance the therapeutic efficacy of a drug, particularly for drugs that require controlled release, targeted delivery, or improved solubility. Technologies such…

Read More “High Development Costs for Incorporating Advanced Drug Delivery Technologies in Capsules” »

Difficulty in Formulating Capsules with Delayed-Release Coating Addressing the Difficulty in Formulating Capsules with Delayed-Release Coating Context Delayed-release capsules are designed to release their active pharmaceutical ingredient (API) after a specified period of time or under specific conditions, such as in the small intestine rather than the stomach. This is particularly useful for drugs that…

Read More “Difficulty in Formulating Capsules with Delayed-Release Coating” »

Variability in Shell Integrity Due to Environmental Factors Addressing Variability in Shell Integrity Due to Environmental Factors Context The integrity of capsule shells is critical for maintaining the stability and performance of pharmaceutical products. Capsules are sensitive to various environmental factors, such as temperature, humidity, and storage conditions, which can impact their physical properties. These…

Read More “Variability in Shell Integrity Due to Environmental Factors” »

Difficulty in Designing Bioequivalent Formulations for Generic Capsules Addressing the Difficulty in Designing Bioequivalent Formulations for Generic Capsules Context Bioequivalence is a critical consideration in the development of generic drug formulations. For a generic drug to be considered equivalent to its branded counterpart, it must demonstrate that the rate and extent of absorption of the…

Read More “Difficulty in Designing Bioequivalent Formulations for Generic Capsules” »

Problems with Shell Discoloration Due to Excipients Interactions Addressing Problems with Shell Discoloration Due to Excipients Interactions Context Discoloration of capsule shells is a common issue encountered during the development and storage of pharmaceutical products. This problem can arise from interactions between the capsule shell material (such as gelatin or HPMC) and the excipients used…

Read More “Problems with Shell Discoloration Due to Excipients Interactions” »

Inadequate Data on Drug Release Kinetics During Development Addressing Inadequate Data on Drug Release Kinetics During Development Context One of the most critical aspects of pharmaceutical formulation development is understanding the drug release kinetics to ensure consistent therapeutic efficacy and safety. However, inadequate data on drug release kinetics during the early stages of formulation development…

Read More “Inadequate Data on Drug Release Kinetics During Development” »

Limited Options for Plasticizers Suitable for Pharmaceutical-Grade Gelatin Addressing the Limited Options for Plasticizers Suitable for Pharmaceutical-Grade Gelatin Context Plasticizers are essential in the production of gelatin capsules, as they improve the flexibility, ease of processing, and stability of the capsule shell. However, the number of plasticizers that are suitable for use in pharmaceutical-grade gelatin…

Read More “Limited Options for Plasticizers Suitable for Pharmaceutical-Grade Gelatin” »

Challenges in Encapsulating Sticky Powders in Hard Gelatin Capsules Addressing Challenges in Encapsulating Sticky Powders in Hard Gelatin Capsules Context Encapsulating sticky powders into hard gelatin capsules can be a significant challenge in pharmaceutical manufacturing. Sticky powders tend to form clumps or agglomerates, making it difficult to ensure uniform fill weights and proper capsule filling….

Read More “Challenges in Encapsulating Sticky Powders in Hard Gelatin Capsules” »

High Excipient-to-Drug Ratio Required for Certain Formulations Addressing the High Excipient-to-Drug Ratio Required for Certain Formulations Context In pharmaceutical formulations, particularly for low-dose drugs, achieving the desired therapeutic effect can often require the use of a large volume of excipients in the final dosage form. This leads to a high excipient-to-drug ratio, which can result…

Read More “High Excipient-to-Drug Ratio Required for Certain Formulations” »